Cargando…

Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo

Detalles Bibliográficos
Autores principales:	Liu, Jia, Dong, Bing-Fei, Wang, Pei-Song, Ren, Pei-You, Xue, Shuai, Zhang, Xiao-Nan, Han, Zhe, Chen, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931839/ https://www.ncbi.nlm.nih.gov/pubmed/35234269 http://dx.doi.org/10.3892/or.2022.8297

Ejemplares similares

[Retracted] MicroRNA‑744 suppresses cell proliferation and invasion of papillary thyroid cancer by directly targeting NOB1
por: Liu, Haixia, et al.
Publicado: (2023)

MicroRNA-363-3p downregulation in papillary thyroid cancer inhibits tumor progression by targeting NOB1
por: Dong, Su, et al.
Publicado: (2021)

Retraction: MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
por: Lin, Yang, et al.
Publicado: (2023)

Retraction Note: High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
por: Liu, Kun, et al.
Publicado: (2023)

Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin
por: Qu, Yang, et al.
Publicado: (2022)

Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells
por: CHEN, BINGPENG, et al.
Publicado: (2014)

Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells
por: Chen, Bingpeng, et al.
Publicado: (2022)

miR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12
por: Dong, Su, et al.
Publicado: (2021)

miR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6
por: Wen, Qiang, et al.
Publicado: (2021)

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2022)

MicroRNA-766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway
por: Zhao, Jianjie, et al.
Publicado: (2022)

miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction]
Publicado: (2021)

MicroRNA-509 targets PAX6 to inhibit cell proliferation and invasion in papillary thyroid carcinoma
por: Zhang, Shuilong, et al.
Publicado: (2022)

Retracted: PRR15 Is a Novel Diagnostic and Prognostic Biomarker in Papillary Thyroid Cancer and Modulates the Tumor Microenvironment
por: Oncology, Journal of
Publicado: (2023)

Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
Publicado: (2022)

Retraction Notice to: Circular RNA Profiling Reveals Exosomal circ_0006156 as a Novel Biomarker in Papillary Thyroid Cancer
por: Wu, Guojun, et al.
Publicado: (2022)

MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
por: Zhuang, Juhua, et al.
Publicado: (2022)

Retraction: MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF
por: Wang, Peisong, et al.
Publicado: (2022)

Retracted: Antitumor Effects of 10058-F4 and Curcumin in Combination Therapy for Pancreatic Cancer In Vitro and In Vivo
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: miR-26a and its Target CKS2 Modulate Cell Growth and Tumorigenesis of Papillary Thyroid Carcinoma
Publicado: (2021)

LncRNA SNHG16 Drives Proliferation and Invasion of Papillary Thyroid Cancer Through Modulation of miR-497 [Retraction]
Publicado: (2021)

microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction]
Publicado: (2021)

miR-497 Inhibited Proliferation, Migration and Invasion of Thyroid Papillary Carcinoma Cells by Negatively Regulating YAP1 Expression [Retraction]
Publicado: (2023)

Retracted: LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Structural and functional analysis of the archaeal endonuclease Nob1
por: Veith, Thomas, et al.
Publicado: (2012)

Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Publicado: (2022)

MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction]
Publicado: (2021)

In vitro antitumor activity of the ethyl acetate extract Potentilla chinensis in osteosarcoma cancer cells
por: Wan, Guang, et al.
Publicado: (2021)

[Retracted] Hesperidin exhibits in vitro and in vivo antitumor effects in human osteosarcoma MG‑63 cells and xenograft mice models via inhibition of cell migration and invasion, cell cycle arrest and induction of mitochondrial‑mediated apoptosis
por: Du, Guang-Yu, et al.
Publicado: (2023)

Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186–2197.
Publicado: (2023)

Retracted: circFAT1(e2) Promotes Papillary Thyroid Cancer Proliferation, Migration, and Invasion via the miRNA-873/ZEB1 Axis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Preparation of folic acid-conjugated, doxorubicin-loaded, magnetic bovine serum albumin nanospheres and their antitumor effects in vitro and in vivo
por: Yang, Rui, et al.
Publicado: (2014)

Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer
por: Su, Xi, et al.
Publicado: (2020)

Retraction Notice to: circRASSF2 Acts as ceRNA and Promotes Papillary Thyroid Carcinoma Progression through miR-1178/TLR4 Signaling Pathway
por: Wu, Guojun, et al.
Publicado: (2021)

Survey of the nob5 mutation in C3H substrains
por: Chang, Bo
Publicado: (2015)

Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2019)

Retraction Notice to: Silencing Long Non-coding RNA LINC01224 Inhibits Hepatocellular Carcinoma Progression via MicroRNA-330-5p-Induced Inhibition of CHEK1
por: Gong, Dan, et al.
Publicado: (2022)

Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
Publicado: (2019)

2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells
por: Wang, Shuo-Yu, et al.
Publicado: (2015)

Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
por: Xue, Shuai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sb4qeiqvbtf8i1n6p7gbmjbbv6